Imereti

Imereti

The Institute of Tissue Regenerative Medicine (IMERETI), is a private biopharmaceutical company that aims to offer new possibilities and therapeutic advances by creating safe, effective and quality drugs. All this related with regenerative and restorative medicine.

For this, IMERETI carries out research projects and clinical trials related to regenerative medicine, and the development of new biomedical products and biomaterials of its own and others.

In short, IMERETI is committed to the research and development of biological medicines and advanced second-generation therapies, thus avoiding all the distribution and marketing problems associated with this type of medicine, which will significantly reduce the costs associated with the manufacturing and control and will facilitate the arrival of this type of products to health systems.

Thus, new therapeutic strategies will be established, born in the world of academia, which will contribute to offering new opportunities for certain diseases that until now lack effective treatments, improving the quality of life of patients.

Website

Mission Mission

IMERETI is a company created for society, given its principles and the values it contributes, allowing the scientific advances achieved in the academy to become industrialized, turning into new biotechnological treatments that improve the quality of life of patients who today they do not have an effective treatment for their disease.

Vision Vision

IMERETI is a biopharmaceutical company specialized in research projects related to Regenerative Medicine and Biotechnology.
It is a company created for society, given its principles and the values it contributes, being part of the advances in science through the development of new personalized biological treatments and new biomedical products. Its R&D strategy is in line with the strategy of the company, focusing, on the one hand, as mentioned above, on basic biomedical research, and on the other, in the development of the regulatory process and the offering of highly qualified and specialized services to third parties.
Currently, the interest shown in this type of therapy is high, which represents an opportunity for IMERETI that will allow it to establish collaborations to expand the therapies that will be given to patients. In fact, the company works closely with Technology Centers, Universities, etc., with the aim of being at the forefront in the field of regenerative medicine, biomedical and biomaterial products and offering new possibilities and therapeutic advances by creating safe medications, effective and quality.

Values Values

IMERETI is a company that always seeks the development of next-generation therapeutic strategies with the aim of improving the quality of life of patients. It is a company sensitized and committed to the environment, being within its philosophy the reduction of environmental impact in relation to the development of its projects, aspects such as recycling and achieving maximum energy efficiency in its facilities being of utmost importance to the company , while maintaining the necessary requirements in its biopharmaceutical plant facilities.

Imereti Services
Manufacturer to third parties of biotechnological drugs under GMP conditions.
Manufacturer to third parties of biotechnological drugs under GMP conditions.
Full development of the life cycle of a product born in the academy.
Full development of the life cycle of a product born in the academy.
Quality control to third parties for medicines for human use.
Quality control to third parties for medicines for human use.
Training: Theoretical, theoretical-practical and practical courses in cellular, molecular and registry biology.
Training: Theoretical, theoretical-practical and practical courses in cellular, molecular and registry biology.
Net-Pharma news

Tradichem uses Piab’s vacuum conveyor to miniaturize active pharma ingredients

Size matters – particularly in competitive markets such as pharma and neutraceuticals due to its ...

Read more

Tradichem creates the first in the world GMP sites for API compaction and granulation with the cutting edge Hipering technology

The GMP site , also know as TIS, is running since November 2017. TIS has been GMP recertified in ...

Read more